Anne-Marie Koop

150 of oxidative stress, inflammation and nitric oxide. Eur J Pharm Sci L.A. Ahmed, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt; 2014; 62 :161–170. 70. Frazziano G, Ghouleh I Al, Baust J, Shiva S, Champion HC, Pagano PJ. Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: Indications for a seminal role for mitochondrial Nox4. Am J Physiol - Hear Circ Physiol P. J. Pagano, Dept. of Pharmacology and Chemical Biology, Vascular Medicine Institute, Univ. of Pittsburgh School of Medicine, Thomas E. Starzl Biomedical Science Tower, Pittsburgh, PA 15261, United States; 2014;306:H197–H205. 71. Nergui S, Fukumoto Y, Do.e Z, Nakajima S, Shimizu T, Ikeda S, Elias-Al-Mamun M, Shimokawa H. Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension. Circ J Y. Fukumoto, Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8574, Japan; 2014;78:1465–1474. 72. Ahmed LA, Obaid AA, Zaki HF, Agha AM. Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline- induced pulmonary hypertension in rats. Eur J Pharmacol 2014;740:379–387. 73. ZhangW-H, Qiu M-H, Wang X-J, Sun K, Zheng Y, Jing Z-C. Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension. Respir Res Y. Zheng, First Hospital of Jilin University, Center of Cardiovascular Disease, Changchun, China; 2014;15. 74. Tatebe S, Fukumoto Y, Oikawa-Wakayama M, Sugimura K, Satoh K, Miura Y, Aoki T, Nochioka K, Miura M, Yamamoto S, Tashiro M, Kagaya Y, Shimokawa H. Enhanced [18F] fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study. Eur Heart J Cardiovasc Imaging England; 2014;15:666–672. 75. Yang T, Wang L, Xiong C-M, He J-G, Zhang Y, Gu Q, Zhao Z-H, Ni X-H, Fang W, Liu Z-H. The ratio of 18F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function. Clin Nucl Med C.-M. Xiong, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences, Xicheng Direct, Beijing, 100037, China; 2014;39:426–430. 76. Paulin R, Sutendra G, Gurtu V, Dromparis P, Haromy A, Provencher S, Bonnet S, Michelakis ED. A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension. Circ Res E.D. Michelakis, Department of Medicine, Cardiology, University of Alberta, Edmonton, Canada; 2015;116:56–69. 77. Moreira-Gonçalves D, Ferreira R, Fonseca H, Padrão AI, Moreno N, Silva AF, Vasques- Nóvoa F, Gonçalves N, Vieira S, Santos M, Amado F, Duarte JA, Leite-Moreira AF, Henriques-Coelho T. Cardioprotective effects of early and late aerobic exercise training in experimental pulmonary arterial hypertension. Basic Res Cardi ol 2015;110:57. 78. BorgdorffMAJ, KoopAMC, Bloks VW, Dickinson MG, Steendijk P, Sillje HHW,Wiechen MPH van, Berger RMF, Bartelds B. Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction. J Mol Cell Cardiol Elsevier Ltd; 2015;79:244–253. 79. Balestra GM, Mik EG, Eerbeek O, Specht PAC, Laarse WJ van der, Zuurbier CJ. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: Mitochondrial inhibition as driver of cardiac failure? Respir Res C.J.